Introduction
Casirivimab & Imdevimab Combo Pack is a prescription medication that contains the active ingredients Casirivimab and Imdevimab. It is also known by its generic name, Casirivimab/Imdevimab. This medication is used for the treatment of COVID-19 in certain patients.
Uses
Casirivimab & Imdevimab Combo Pack is prescribed for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) who are at high risk of progressing to severe COVID-19. It is used to reduce the risk of hospitalization and emergency room visits in these patients.
Dosage and Administration
The dosage and administration of Casirivimab & Imdevimab Combo Pack should be determined by a healthcare professional and will depend on factors such as the patient’s weight and age. It is administered as an intravenous infusion over a period of time. The healthcare professional will provide the specific instructions for the administration of the medication.
Mechanism of Action
Casirivimab & Imdevimab Combo Pack works by binding to a specific protein on the surface of the SARS-CoV-2 virus, which causes COVID-19. By binding to this protein, Casirivimab and Imdevimab prevent the virus from entering and infecting human cells. This helps to reduce viral load and the severity of COVID-19 symptoms.
Side Effects
Common side effects of Casirivimab & Imdevimab Combo Pack may include nausea, fever, headache, fatigue, and diarrhea. These side effects are generally mild and temporary. However, if you experience any serious side effects such as severe allergic reactions, difficulty breathing, or chest pain, seek immediate medical attention.
Drug Interactions
There are no known drug interactions with Casirivimab & Imdevimab Combo Pack at this time. However, it is always important to inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid any potential interactions.
Precautions
Before using Casirivimab & Imdevimab Combo Pack, inform your healthcare professional about any allergies you may have, as well as any other medications or substances you are currently using. This medication should not be used in patients with a known history of severe allergic reactions to Casirivimab, Imdevimab, or any other ingredients in the injection.
Storage
Patient Tips
- Follow the instructions provided by your healthcare professional for the administration of Casirivimab & Imdevimab Combo Pack.
- If you have any questions or concerns about the medication, do not hesitate to ask your healthcare professional.
- complete the full course of treatment as prescribed, even if you start feeling better.
- Keep all follow-up appointments with your healthcare professional to monitor your progress and response to the medication.
- If you experience any unusual symptoms or side effects, contact your healthcare professional immediately.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Casirivimab and imdevimab (Drugs.com) [Accessed 11 Jun. 2024] (online) Available at:
- casirivimab (regn10933) 120 mg/ml intravenous solution (1 of 2) (eua) antiviral monoclonal antibodies – sars-cov-2 coronavirus (RX) [Accessed 15 Jun. 2024] (online) Available at:
- Casirivimab and Imdevimab Injection (MedlinePlus) [Accessed 30 Jun. 2024] (online) Available at:
- [No authors listed] Casirivimab. 2023 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. [Accessed 14 Jun. 2024] Available at:
Reviews
There are no reviews yet.